Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of ALK-Rearranged Lung Cancer.
Arai S, Takeuchi S, Fukuda K, Taniguchi H, Nishiyama A, Tanimoto A, Satouchi M, Yamashita K, Ohtsubo K, Nanjo S, Kumagai T, Katayama R, Nishio M, Zheng MM, Wu YL, Nishihara H, Yamamoto T, Nakada M, Yano S.
Arai S, et al. Among authors: zheng mm.
J Thorac Oncol. 2020 May;15(5):752-765. doi: 10.1016/j.jtho.2020.01.001. Epub 2020 Jan 21.
J Thorac Oncol. 2020.
PMID: 31972351
Free article.